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ABSTRACT 51 
Objective 52 
Current evidence on the association between body mass index (BMI) and age at menopause 53 
remains unclear. We investigated the relationship between BMI and age at menopause using 54 
data from 11 prospective studies.  55 
Methods 56 
A total of 24,196 women who experienced menopause after recruitment was included. Baseline 57 
BMI was categorised according to the WHO criteria. Age at menopause, confirmed by natural 58 
cessation of menses IRUmonths, was categorised as <45 years (early menopause), 45-49, 59 
50-51 (reference category), 52-53, 54-55, and 56 years (late age at menopause). We used 60 
multinomial logistic regression models to estimate multivariable relative risk ratios (RRRs) 61 
and 95% confidence intervals (CI) for the associations between BMI and age at menopause. 62 
Results 63 
The mean (standard deviation) age at menopause was 51.4 (3.3) years, with 2.5% of the women 64 
having early and 8.1% late menopause. Compared with those with normal BMI (18.5-24.9 65 
kg/m2), underweight women were at a higher risk of early menopause (RRR 2.15, 95% CI 1.50-66 
3.06), while overweight (1.52, 1.31-1.77) and obese women (1.54, 1.18-2.01) were at increased 67 
risk of late menopause. Overweight and obesity were also significantly associated with around 68 
20% increased risk of menopause at ages 52-53 and 54-55 years. We observed no association 69 
between underweight and late menopause. The risk of early menopause was higher among 70 
obese women albeit not significant (1.23, 0.89-1.71).  71 
Conclusion 72 
Underweight women had over twice the risk of experiencing early menopause, while 73 
overweight and obese women had over 50% higher risk of experiencing late menopause. 74 
 75 
Keywords   Underweight ·  Obesity · Age at menopause · Prospective studies  76 
 77 
  78 
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INTRODUCTION  79 
Age at natural menopause, defined as the time when a woman has experienced 12 consecutive 80 
months of amenorrhea, has a range of health implications as a marker for biological ageing and 81 
subsequent morbidity and mortality. Early menopause is associated with higher risk of 82 
cardiovascular disease (CVD) mortality, all-cause mortality [1, 2], type 2 diabetes [3], low 83 
bone density and osteoporosis [4], while late menopause increases the risk of breast cancer [5] 84 
and probably endometrial cancer [6].  85 
 86 
In high-income countries, average age at menopause is 51.4 years [7], but varies between 87 
populations from 49 to 52 years [8]. Factors shown to be associated with the timing of 88 
menopause include genetic, demographic, and reproductive characteristics, as well as lifestyle 89 
and body weight [9]. If a mother has an early menopause, her daughter is more likely to also 90 
reach menopause early [8, 9]. Early menarche and nulliparity are both linked with earlier age 91 
at menopause [10] as is also lower education and low socioeconomic status [11]. Cigarette 92 
smoking, the most established modifiable determinant of age at menopause, hastens the onset 93 
of menopause by almost a year [11]. 94 
 95 
Another potentially modifiable factor that might affect age at menopause is body mass index 96 
(BMI). To date, evidence on the relationship between BMI and age at menopause has been 97 
inconsistent. High BMI has been linked to both later [7, 12, 11, 13-15], and earlier menopause 98 
[16, 17] whilst some studies have found no association [18-20]. Low BMI has been related to 99 
early menopause [21, 14], but some studies report no significant relationship [22, 17]. 100 
Inconsistent results across studies could be due to differences in study samples, study designs, 101 
classification of BMI levels, and adjustment for confounding variables.  102 
 103 
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Our aim was to investigate the relationship between different categories of BMI and the timing 104 
of age at menopause across several studies that include data from multiple racial/ethnic groups 105 
of women, whilst taking into account a range of potential confounding factors. We have 106 
available pooled participant-level data for over 24,000 postmenopausal women from 107 
prospective studies contributing to the International Collaboration for a Life Course Approach 108 
to Reproductive Health and Chronic Disease Events (InterLACE) [23, 24].  109 
 110 
MATERIALS AND METHODS 111 
Study participants  112 
InterLACE has brought together 23 observational, mostly longitudinal cohort studies with data 113 
on women’s health as previously described in detail [23, 24]. Participating studies collected 114 
survey data on key reproductive, sociodemographic, lifestyle, and disease outcome variables. 115 
In the present analyses, we used prospective design to examine the association between 116 
baseline BMI categories and age at menopause which occurred after baseline survey. Thus, 117 
women who experienced menopause before baseline were excluded (n=37,691). This pooled 118 
study therefore consisted of 24,196 women who were premenopausal at baseline and reached 119 
menopause at a subsequent survey, had reported age at natural menopause, and had complete 120 
data on BMI as well as key covariates at baseline, including smoking status, education level, 121 
race/ethnicity, and number of children. As a consequence, 11 prospective studies were included 122 
(Table 1). NSHD (1946 British Birth Cohort) and NCDS (1958 British Birth Cohort) are birth 123 
cohort studies which collected information on women’s reproductive health from 1993 (women 124 
aged 47 years) and 2008 (women aged 50 years), respectively. The sampling strategy with 125 
exclusion criteria is presented in Supplementary Figure 1. 126 
 127 
Outcome and exposure variables 128 
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The outcome was age at menopause, confirmed by at least 12 months of cessation of menses 129 
that did not result from interventions (such as bilateral oophorectomy, hysterectomy, 130 
chemotherapy, or radiotherapy); women having these procedures were excluded. For women 131 
who were currently taking hormone replacement therapy (HRT) or oral contraceptive pills 132 
(OCPs) (unless natural or surgical menopausal was specifically reported), we defined their 133 
menopausal status separately as “unknown due to hormone use”, and the data on menopause 134 
age were not available for this group [24]. Age at menopause was categorised as <45 years 135 
(early menopause), 45-49, 50-51 (reference category), 52-53, 54-55, or 56 years and above 136 
(late menopause). 137 
 138 
The exposure variable was BMI, based on either self-recorded or measured data at the baseline 139 
survey. BMI was calculated as weight (kg) divided by height squared (m2) and was categorised 140 
according to the WHO criteria [25], into: underweight (<18.5 kg/m2), normal weight (18.5 to 141 
24.9 kg/m2), overweight (25 to 29.9 kg/m2) and obese (30 kg/m2). Because the two birth 142 
cohort studies (NSHD and NCDS) collected BMI information at each follow-up survey after 143 
birth, BMI from the survey before women reported having undergone menopause was treated 144 
as the baseline. 145 
 146 
The following demographic and lifestyle factors reported at baseline surveys (or at mid age 147 
surveys for the birth cohort studies) were included in the analysis as covariates: smoking status 148 
(never smokers, past smokers, and current smokers), years of education –12, and >12 149 
years), race/ethnicity (Caucasian-European, Caucasian-Australian/New Zealand, Caucasian-150 
American/Canadian, and non-Caucasian (including Asian, African Americans, Middle Eastern, 151 
etc.)), number of children (none, 1, 2, and 3 or more children) and age at menarche (11, 12, 152 
13, 14, and 15 years or more). Employment and marital status were not included as covariates 153 
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for missing in MCCS and NCDS study. Also, genetic factors, early life factors and 154 
comorbidities (e.g., cancer and chronic obstructive pulmonary disease(COPD)) were 155 
unmeasured and may lead to residual confounding. 156 
 157 
Statistical analysis 158 
We used multinomial (polytomous) logistic regression models with six categories of outcome 159 
for age at menopause (<45, 45-49, 50-51, 52-53, 54-55, 56 years and older) to examine the 160 
associations between baseline BMI categories and age at menopause. We used age 50-51 years 161 
at menopause as reference group for the outcome, and BMI 18.5 to 24.9 kg/m2 as reference 162 
group for the exposure. Statistical models were adjusted for smoking status, education level, 163 
race/ethnicity, and number of children. Variables were retained in model at P  0.05. 164 
Multivariable relative risk ratios (RRRs)[26] and 95% confidence intervals (95% CI) were 165 
estimated for the relation between BMI categories and each category of age at menopause, 166 
adjusting for covariates. Age at menarche is also a potential confounder that could affect the 167 
association between BMI and age at menopause. Thus, the models were additionally adjusted 168 
for age at menarche but with only ten studies included in the analysis (n=21,991), because no 169 
information on age at menarche was available from the WHITEHALL study. We also used 170 
fractional-polynomial model to examine possible non-linear relationship between BMI and age 171 
at menopause by treating them as continuous variables using total sample of 24,196 women. 172 
 173 
We undertook several sensitivity analyses to examine the robustness of our findings. To 174 
minimise the possible influence of peri-menopause on BMI at midlife, we analysed the 175 
association of BMI with age at menopause for women who experienced menopause at least 176 
one year, two years, three years, and five years after their baseline BMI was collected. Body 177 
weight may increase with age, and women enrolled at older ages are likely to have a higher 178 
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BMI and have a higher chance of later menopause. We therefore performed a sensitivity 179 
analysis by excluding women who enrolled after the age of 50 years. Specific BMI cut-off 180 
points have been recommended for Asians [27]. Hence, we also did a sensitivity analysis by 181 
using the “Asian BMI criteria” (underweight, <18.5 kg/m2; normal weight, 18.5–22.9 kg/m2; 182 
overweight, 23-27.4 kg/m2; obese,  27.5 kg/m2) for women of Asian ethnicity. We also 183 
performed an analysis excluding women whose BMI was obtained by self-reported height and 184 
weight at baseline. Additionally, we performed study-specific regression and random-effects 185 
meta-analysis for studies which had sufficient data to estimate the between-study heterogeneity 186 
in the effect size estimates. 187 
 188 
The SURVEYLOGISTIC procedure was carried out with the generalised logit link that 189 
estimates sampling errors based on the clustered sample survey from multiple studies and 190 
incorporates that in the estimates. All tests of statistical hypothesis were two-sided, and the 191 
level of significance was 5%. Statistical analyses were performed using SAS (version 9.4, SAS 192 
Institute Inc, Cary, NC), and the METAN command in Stata (version 14.0, Stata Corp., College 193 
Station, TX) was used to perform meta-analysis. 194 
 195 
Each study in the InterLACE consortium has been undertaken with ethical approval from the 196 
Institutional Review Board or Human Research Ethics Committee at each participating 197 
institution, and all participants provided consent for that study. 198 
RESULTS 199 
Study characteristics  200 
Altogether 24,196 women experienced natural menopause after baseline. Most of them were 201 
born between 1940 and 1949 (Table 1). The mean (standard deviation, SD) BMI was 24.9 (4.8) 202 
kg/m2 (median 23.9 kg/m2, interquartile range 21.7-26.9 kg/m2), with 1.6%, 26.5%, and 12.8% 203 
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of the women underweight, overweight, and obese, respectively. The mean age at baseline BMI 204 
was 46.0 (3.8) years, and the mean age at menopause was 51.4 (3.3) years (median 52.0 years, 205 
interquartile range 50.0-54.0years) (supplementary Tables S1 and S2). A small percentage 206 
(2.5%) had early menopause (age at menopause <45 years) and 8.1% late menopause (age at 207 
menopause \HDUV.  208 
 209 
Compared with the women who were never-smokers or past smokers, women who were current 210 
smokers had the highest proportion of underweight (2.7%) and early menopause (4.0%) and 211 
the lowest proportion of late menopause (5.5%) (Table 2). The proportions of women who 212 
were both underweight (from 2.2% to 1.3%) and had early menopause (from 3.8% to 1.9%) 213 
decreased with increasing number of children, while the proportions of overweight/obese 214 
women and those with late menopause increased. Conversely, with increasing age at menarche, 215 
the proportions of women in the underweight category and with late menopause increased, 216 
while the proportions of overweight/obese women and those with early menopause decreased. 217 
 218 
Association between BMI and age at menopause 219 
BMI was positively associated with age at menopause, and the strength of this relationship 220 
remained after adjusting for race/ethnicity, education level, smoking status, and number of 221 
children (Table 3).  Compared with normal weight women, underweight women had more than 222 
twice the risk of experiencing early menopause (RRR: 2.15, 95% CI 1.50, 3.06; age at 223 
menopause 50-51 years as the reference group). The overweight and obese categories were 224 
both associated with late menopause, with multivariable RRR of 1.52 (95% CI 1.31, 1.77) and 225 
1.54 (95% CI 1.18, 2.01), respectively. Being overweight/obese was also significantly 226 
associated with age at menopause categories of 52-53 and 54-55 with an approximately 20% 227 
higher risk (RRRs range from 1.20 to 1.26). The associations were also graphically 228 
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demonstrated in Figure 1.  We observed that the association appeared linear in the overweight 229 
group, while it followed a semi-J shape association in the underweight and obese groups. An 230 
increased risk of early menopause was not found to be significant for the obese group (RRR: 231 
1.23, 95% CI 0.89, 1.71). When further adjusted for age at menarche (i.e. WHITEHALL study 232 
was not included, data not shown), the estimates remained unchanged. In addition, when we 233 
considered BMI and age at menopause as continuous variables, a nonlinear relationship was 234 
observed between BMI and age at menopause (Supplementary Fig. 2). 235 
 236 
Sensitivity analyses  237 
The results of the sensitivity analysis which took into account whether onset of menopause 238 
occurred one, two, three, and five years after baseline BMI indicated that associations remained 239 
for all groups and were particularly strong for the women in the underweight or obese 240 
categories with BMI data at least five years prior to the onset of natural menopause (n=13,519) 241 
(Table 4). These underweight women were at over 3-fold higher risk of experiencing early 242 
menopause (RRR 3.11, 95% CI 2.23- 4.44), while obese women were at nearly twice the risk 243 
of having late menopause (RRR 1.80, 95% CI 1.41-2.31), compared with women with normal 244 
BMI. Sensitivity analyses that excluded women who enrolled after 50 years of age or women 245 
with self-reported BMI and that used “Asian BMI criteria” for women in Asian ethnicity all 246 
showed results consistent with those from main analyses (data not shown). 247 
 248 
Meta-analyses 249 
Of the 11 studies, four had sufficient data to conduct study-specific analyses of the relation of 250 
underweight with early menopause, and eight had sufficient data to contribute to the study-251 
specific analyses of the estimates of the association of overweight and obesity with late 252 
menopause (Figure 2). Random-effects meta-analysis of the estimates from the four studies 253 
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produced a pooled RRR of 2.14 (95%CI: 1.21-3.77) for the association of underweight with 254 
early menopause. In addition, meta-analysis from the eight studies resulted in a pooled RRR 255 
of 1.52 (95%CI: 1.29-1.79) and 1.35 (95% CI: 1.14-1.60) for the effect of overweight and 256 
obesity on late menopause, respectively. We found no significant heterogeneity between 257 
studies (P > 0.05).  258 
 259 
DISCUSSION 260 
Our results indicate that underweight women are over twice as likely to experience early 261 
menopause, and overweight and obese women are 50% more likely to have late menopause. 262 
These associations were stronger for women with underweight or obese BMI being reported at 263 
least five years prior to onset of menopause. These findings provide strong evidence that being 264 
underweight may trigger early menopause and confirm that being overweight or obese may 265 
delay menopause.   266 
 267 
In line with our findings, several studies have reported higher BMI to be significantly 268 
associated with later menopause [7, 11, 13-15], although some studies have reported no 269 
association [18-21]. A recent systematic review reported a weak association [hazard ratio (HR) 270 
(95% CI): 0.93 (0.91, 0.96)], indicating that overweight women were less likely to experience 271 
an earlier menopause. Yet no relationship was found between obesity and later menopause, 272 
compared with women with normal BMI [28]. The differences between our findings and those 273 
of the systematic review might have arisen because the HRs of the systematic review were 274 
extracted and pooled from studies with a mix of designs (heterogeneity test: P < 0.01), 275 
including five cross-sectional studies, three prospective cohorts, and one retrospective cohort. 276 
In contrast, all studies included in our present analyses had a prospective design. In addition, 277 
different BMI cut-off points were used among studies, and some studies did not control for 278 
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smoking, an important confounder. Our findings indicate that being overweight or obese entails 279 
a 50% higher risk of late menopause, after controlling for confounding, including smoking. 280 
Two previous cross-sectional studies with limited sample size found overweight [16] or obesity 281 
[17] related to earlier menopause. In our study, a higher RRR 1.23 (95%CI 0.89, 1.71) for early 282 
menopause among obese women was suggested but not significant, potentially due to the small 283 
number of cases. Given the semi-J shape of the associations between BMI and early menopause, 284 
the overall findings suggest obesity was not only associated with late menopause but also has 285 
some association with early menopause. This was also supported by the nonlinear relationship 286 
we observed by treating BMI and age at menopause as continuous variables.  287 
 288 
The link between overweight or obesity and late age at menopause may be explained by the 289 
complex functions of adipose tissue. Adipose tissue functions as a specialized endocrine and 290 
paracrine organ. One of its roles is the production of an array of adipokines [29]. Leptin, the 291 
most investigated adipokine, is produced and secreted in proportion to body fat mass and 292 
inhibits hunger. It communicates information about body energy reserves, nutritional state, and 293 
metabolic shifts to the reproductive axis. Leptin can act peripherally at the ovary or centrally 294 
at the hypothalamus to augment female reproductive function [30, 31]. A recent study has 295 
shown that early menopause is associated with low leptin levels [32]. However, specific roles 296 
for adipose tissue and adipokines in maintaining cyclicity and postponing menopause remain 297 
to be studied. In addition, Sowers et al. [33] has found the W\SH  ȕ+6' JHQHV were 298 
associated with five single nucleotide polymorphism (SNPs) variation in obese women. These 299 
SNPs variation were related to a lower estradiol’s decline rate in the menopausal transition 300 
period, and the estradiol’s decline rate in obese women was half that of non-obese women. The 301 
observed genetic correlations between reproductive hormones and BMI may suggest genetic 302 
polymorphisms play a role in the relationship. 303 
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 304 
Our major finding was that underweight BMI was linked to early menopause. Previous studies 305 
which had women with underweight or lower BMI as the reference group precluded the 306 
possibility of examining the effect of lower BMI directly on age at menopause [19, 7, 13, 15]. 307 
In our study, women with normal BMI formed the reference category, and in comparison, 308 
underweight women had over twice the risk of early menopause. This is consistent with 309 
findings from a cross-sectional study [HR (95% CI): 1.13 (1.02, 1.25)] [14] and a prospective 310 
study [HR (95% CI): 1.30 (1.02, 1.65)] [21], although our adjusted risk estimate is greater. 311 
Even though the prevalence of underweight among mid-age women was low (only 1.6%, 312 
N=398) in this study), and the prevalence of early menopause was less than 5%, the study had 313 
sufficient statistical power to detect an association based on the 24 cases of underweight 314 
women with early menopause (RRR: 2.15, 95%CI: 1.50-3.06). Being underweight may trigger 315 
early menopause as a result of malnutrition [34], concurrent or previous chronic illness (such 316 
as chronic obstructive pulmonary disease) [35], over-exercising [36], and weight-loss diet [18]. 317 
Also, less adipose tissue leads to lower leptin levels, which also relate to early menopause [32]. 318 
 319 
Weight change during the period of menopausal transition may influence the association 320 
between overweight/obesity and age at menopause. Because some studies have found that the 321 
menopausal transition is associated with weight gain [37, 38], causal inference about the 322 
relationship between overweight/obesity and age at menopause is complicated if women 323 
reported being overweight/obese during their menopausal transition period. Our sensitivity 324 
analysis, which examined the association for women who experienced onset of menopause 325 
from one to five years after the collection of baseline BMI data, showed that both the relations 326 
of underweight and overweight/obesity to age at menopause were maintained or strengthened, 327 
especially for women with BMI not in the normal range five or more years prior to their onset 328 
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of menopause. These stronger results from the sensitivity analyses suggest that the associations 329 
of BMI in the main analysis may have been partly attenuated by baseline BMI collected in the 330 
perimenopausal period. However, the association between menopausal transition and weight 331 
change may not be strong. Using longitudinal data, SWAN showed that menopausal status was 332 
not associated with the increase in weight but more with ageing, and weight gain preceded 333 
changes in serum hormone levels [39]. Also, weight increases with age in many populations 334 
[40]. Thus, the women who enrolled at older ages would tend to have had a higher BMI and 335 
have a higher risk of later menopause. Nevertheless, in a sensitivity analysis excluding women 336 
who enrolled after the age of 50 years, we found results similar to those from the main analyses. 337 
 338 
The main strength of this study was the use of pooled individual-level data from 11 prospective 339 
studies across different geographic regions and racial/ethnic populations. This provided a large 340 
number of women who were followed-up prospectively from pre or peri-menopause at baseline 341 
to post-menopause. The large sample size also ensured sufficient power to analyse the 342 
association of BMI levels with six categories of age at menopause, especially with early and 343 
late menopause, while many previous studies were limited by small sample sizes or short 344 
lengths of follow-up [18, 19, 41, 22, 42, 21] and were cross-sectional or retrospective in nature 345 
[20, 7, 17, 43, 14, 15]. Also, the participant-level data in InterLACE enabled harmonising 346 
variables using common definitions, coding and cut points which are not usually possible with 347 
meta-analyses of published results. 348 
 349 
A number of limitations also need to be acknowledged. First, InterLACE pooled data mainly 350 
from longitudinal studies of women in midlife, most of whom were enrolled when they were 351 
in their 40s or 50s (except for the birth cohorts). Thus, the mean age of baseline BMI in the 352 
present study was 46.0 years. This limitation restricted our ability to consider an influence of 353 
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BMI at earlier ages. Our results should be applied with some caution to women in younger age 354 
groups. Nevertheless, one individual study (NSHD) in InterLACE found underweight women 355 
at age 36 years had significantly earlier menopause than normal weight women [21]. Two 356 
other/ studies found obesity at age 18 years [44] and higher BMI (BMI in upper 25%) at age 357 
40 or 41 years [41] was linked with later age at menopause. Second, our study only used one 358 
single measurement of BMI at midlife. It would provide a better understanding with the timing 359 
of menopause if the information on BMI history or trajectories of BMI was available. NSHD 360 
study has evaluated the BMI trajectories (from 20-36 years) and age at menopause using a 361 
prospective cohort design and found no significant associations [21]. Although we have 362 
adjusted for a range of confounding factors, some unmeasured confounders, such as genetic 363 
factors, early childhood factors, and comorbidities (e.g., cancer [45] and COPD [35]), could 364 
affect our observed results. Another limitation was that of the 11 prospective studies included, 365 
five of them contributed 31% of the women with self-reported baseline height and weight 366 
which may have led to some degree of bias, but a sensitivity analysis conducted only including 367 
women with measured baseline BMI showed estimates consistent with the main results.  368 
 369 
In summary, in addition to supporting a previously reported association between higher BMI 370 
and later menopause, our study also provides strong evidence that underweight is a risk factor 371 
for early menopause. Underweight women are at increased risk of early age at menopause, 372 
which they should be warned is a risk factor for CVD [1, 2], and osteoporosis [4]. Obese women 373 
are more likely to have late menopause, which is a risk factor for breast cancer and is in addition 374 
to the risks of poor health outcomes directly attributed to obesity [46, 5].  375 
 376 
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Table 1. Characteristics of women in each study of the InterLACE consortium a 
Study Country N 
Age at 
baseline 
Age at last 
follow-up Women's year of birth (%) 
Mean (SD) Mean (SD) 1930-1939 1940-1949 1950+ 
Australian Longitudinal Study on Women’s Health 
(ALSWH) Australia 5505 47.5 (1.4) 63.3 (3.1) - 72.7 27.3 
Melbourne Collaborative Cohort Study (MCCS) Australia 2135 48.2 (4.1) 59.2 (4.7) 14.9 73.8 11.3 
Danish Nurse Cohort Study (DNC) Denmark 145 49.3 (3.4) 63.6 (5.7) 14.5 85.5 - 
Women’s Lifestyle and Health Study (WLH) Sweden 9353 44.7 (3.5) 55.5 (3.7) - 74.6 25.4 
MRC National Survey of Health and Development 
(NSHD)b UK 679 47.0 53.9 - 100.0 - 
National Child Development Study (NCDS)b UK 2135 50.0 54.8 - - 100 
English Longitudinal Study of Ageing (ELSA) UK 600 49.4 (3.6) 59.9 (3.8) 0.5 47.2 52.3 
UK Women's Cohort Study (UKWCS) UK 765 49.3 (3.6) 53.7 (3.5) 0.8 80.0 19.2 
Whitehall II study (WHITEHALL) UK 997 43.3 (4.8) 62.6 (4.9) 25.2 65.1 9.7 
Study of Women's Health Across the Nation 
(SWAN) USA 1779 46.4 (2.6) 56.0 (2.8) - 47.8 52.2 
Seattle Middle Women's Health Study (SMWHS) USA 103 41.8 (4.2) 49.9 (3.8) 1.9 53.4 44.7 
Total  24196 46.5 (3.6) 57.9 (5.0) 2.5 65.3 32.2 
a In this study, the dataset included all women who had complete information on age at natural menopause, body mass index (BMI), smoking status, number of children, education level, 
and ethnicity at the baseline. 
b
 NSHD (1946 British Birth Cohort) and NCDS (1958 British Birth Cohort) first collected information on women’s health in 1993 (aged 47) and 2008 (aged 50), respectively, so we 
used 1993 and 2008 as the baseline year for the InterLACE. 
Abbreviations: InterLACE, International Collaboration for a Life Course Approach to Reproductive Health and Chronic Disease Events; SD, standard deviation. 
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Table 2. Characteristics of women in different classification of body mass index and age at natural menopause (n=24,196) 
Characteristics 
BMI levels (kg/m2)  Age at menopause (years) 
Underweight 
<18.5  
(n=398) 
Normal 
18.5-24.9 
(n=14292) 
Overweight 
25.0-29.9 
(n=6410) 
Obese  

(n=3096) 
 
<45 
(n=602) 
45-49 
(n=5131) 
50-51 
(n=6111) 
52-53 
(n=6084) 
54-55 
(n=4308) 
56 
(n=1960) 
Race/Ethnicity            
Caucasian -Australian 85 (1.5) 3060 (53.9) 1681 (29.6) 856 (15.1)  33 (0.6) 713 (12.5) 1579 (27.8) 1379 (24.3) 1215 (21.4) 763 (13.4) 
Caucasian -European 265 (1.6) 10156 (62.7) 4136 (25.5) 1638 (10.1)  551 (3.4) 3867 (23.9) 3902 (24.1) 4036 (24.9) 2735 (16.9) 1104 (6.8) 
Caucasian -American 22 (2.2) 473 (46.6) 255 (25.1) 264 (26.0)  3 (0.3) 255 (25.1) 264 (26.0) 299 (29.5) 146 (14.4) 47 (4.6) 
Non-Caucasian 26 (2.0) 603 (46.2) 338 (25.9) 338 (25.9)  15 (1.1) 296 (22.7) 366 (28.0) 370 (28.4) 212 (16.2) 46 (3.5) 
Educational attainment           
10 years 131 (1.3) 5240 (52.5) 3054 (30.6) 1562 (15.6)  289 (2.9) 2035 (20.4) 2456 (24.6) 2489 (24.9) 1861 (18.6) 857 (8.6) 
11-12 years 72 (1.7) 2702 (62.0) 1103 (25.3) 483 (11.1)  131 (3.0) 970 (22.2) 1126 (25.8) 1059 (24.3) 742 (17.0) 332 (7.6) 
>12 years 195 (2.0) 6350 (64.5) 2253 (22.9) 1051 (10.7)  182 (1.8) 2126 (21.6) 2529 (25.7) 2536 (25.7) 1705 (17.3) 771 (7.8) 
Smoking status           
Never 198 (1.6) 7067 (57.5) 3354 (27.3) 1662 (13.5)  234 (1.9) 2241 (18.2) 3069 (25.0) 3244 (26.4) 2364 (19.2) 1129 (9.2) 
Past 83 (1.1) 4554 (60.6) 1981 (26.4) 899 (12.0)  191 (2.5) 1621 (21.6) 1932 (25.7) 1864 (24.8) 1318 (17.5) 591 (7.9) 
Current 117 (2.7) 2671 (60.7) 1075 (24.4) 535 (12.2)  177 (4.0) 1269 (28.9) 1110 (25.2) 976 (22.2) 626 (14.2) 240 (5.5) 
Number of children           
0 67 (2.2) 1893 (60.8) 726 (23.3) 426 (13.7)  118 (3.8) 814 (26.2) 821 (26.4) 714 (22.9) 463 (14.9) 182 (5.8) 
1 58 (1.9) 1866 (61.4) 750 (24.7) 365 (12.0)  89 (2.9) 758 (24.9) 738 (24.3) 751 (24.7) 478 (15.7) 225 (7.4) 
2 166 (1.7) 6096 (61.1) 2621 (26.3) 1094 (11.0)  240 (2.4) 2061 (20.7) 2520 (25.3) 2554 (25.6) 1801 (18.1) 801 (8.0) 
3 107 (1.3) 4437 (55.0) 2313 (28.7) 1211 (15.0)  155 (1.9) 1498 (18.6) 2032 (25.2) 2065 (25.6) 1566 (19.4) 752 (9.3) 
Age at menarche (n=21,991)  
         
11 years 24 (0.7) 1535 (45.7) 1029 (30.6) 771 (23.0)  102 (3.0) 791 (23.5) 776 (23.1) 856 (25.5) 558 (16.6) 276 (8.2) 
12 years 54 (1.1) 2790 (56.8) 1364 (27.8) 701 (14.3)  133 (2.7) 1092 (22.2) 1275 (26.0) 1237 (25.2) 831 (16.9) 341 (6.9) 
13 years 87 (1.3) 3953 (61.0) 1684 (26.0) 756 (11.7)  163 (2.5) 1381 (21.3) 1664 (25.7) 1631 (25.2) 1163 (17.9) 478 (7.4) 
14 years 88 (2.0) 2800 (64.8) 1059 (24.5) 376 (8.7)  92 (2.1) 871 (20.1) 1082 (25.0) 1093 (25.3) 794 (18.4) 391 (9.0) 
15 years 84 (2.9) 1937 (66.3) 672 (23.0) 227 (7.8)  37 (1.3) 526 (18.0) 740 (25.3) 714 (24.5) 599 (20.5) 304 (10.4) 
Data were presented as n (%). Abbreviations: BMI, body mass index. 
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Table 3. Unadjusted and adjusted associations of body mass index levels at baseline and age at natural 
menopause  (n=24,196) a 
BMI levels 
(kg/m2) b 
Age at menopause 
(years) n (%) 
Unadjusted  
RRR (95% CI)  
Adjusted for smoking, 
education, ethnicity and 
number of children 
RRR (95% CI) 
Underweight, <18.5   
 <45 24 (6.0) 2.12 (1.46, 3.06) 2.15 (1.50, 3.06) 
 45-49 108 (27.1) 1.11 (0.98, 1.26) 1.08 (0.93, 1.25) 
 50-51 113 (28.4) Reference Reference 
 52-53 83 (20.9) 0.79 (0.59, 1.06) 0.80 (0.59, 1.08) 
 54-55 45 (11.3) 0.61 (0.52, 0.73) 0.64 (0.55, 0.74) 
 56 25 (6.3) 0.83 (0.49, 1.40) 0.87 (0.50, 1.53) 
Overweight, 25.0-29.9   
 <45 125 (2.0) 0.82 (0.66, 1.02) 0.87 (0.69, 1.10) 
 45-49 1215 (19.0) 0.93 (0.84, 1.04) 0.97 (0.89, 1.06) 
 50-51 1514 (23.6) Reference Reference 
 52-53 1686 (26.3) 1.20 (1.07, 1.34) 1.20 (1.06, 1.35) 
 54-55 1235 (19.3) 1.26 (1.15, 1.37) 1.24 (1.14, 1.34) 
 56 635 (9.9) 1.57 (1.33, 1.84) 1.52 (1.31, 1.77) 
Obese, 30.0   
 <45 75 (2.4) 1.02 (0.71, 1.45) 1.23 (0.89, 1.71) 
 45-49 575 (18.6) 0.91 (0.76, 1.09) 0.97 (0.82, 1.14) 
 50-51 732 (23.6) Reference Reference 
 52-53 825 (26.6) 1.21 (1.04, 1.41) 1.22 (1.03, 1.45) 
 54-55 594 (19.2) 1.25 (1.02, 1.54) 1.26 (1.10, 1.45) 
 56 295 (9.5) 1.51 (1.08, 2.10) 1.54 (1.18, 2.01) 
a
 Multinomial logistic regression model was used to estimate relative risk ratio (RRR) and 95% confidence interval 
(95% CI). 
b The normal weight (18.5-24.9) group was taken as reference for the polytomous explanatory variable of BMI, and the 
distribution of age at menopause in this group is: <45, 378 (2.6); 45-49, 3233 (22.6); 50-51, 3752 (26.3); 52-53, 3490 
(24.4); 54-55, 2434 (17.0); 56, 1005 (7.0). 
Abbreviations: BMI, body mass index; RRR, relative risk ratio. 
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Table 4. Relative risk ratio and 95% confidence interval (95%CI) of baseline body mass index levels and age at natural menopause which occurred 1, 2, 3 and 5 years after 
baseline BMI a 
BMI 
levels 
(kg/m2)
b
 
Age at 
menopause 
(years) 
Onset of menopause at least 1 
year after baseline BMI  
(n= 23191) 
Onset of menopause at least 2 
years  after baseline BMI 
(n=20971) 
Onset of menopause at least 3 
years  after baseline BMI 
(n=18400) 
Onset of menopause at least 5 
years  after baseline BMI 
(n=13519) 
Underweight, <18.5 
   
 
<45 2.18 (1.55, 3.08) 2.33 (1.44, 3.80) 2.31 (1.73, 3.09) 3.11 (2.23, 4.33) 
 
45-49 1.08 (0.91, 1.28) 1.13 (0.95, 1.34) 1.11 (0.94, 1.31) 1.23 (1.02, 1.48) 
 
50-51 Reference Reference Reference Reference 
 
52-53 0.82 (0.62, 1.08) 0.85 (0.61, 1.20) 0.82 (0.62, 1.08) 0.81 (0.58, 1.13) 
 
54-55 0.65 (0.57, 0.75) 0.70 (0.59, 0.82) 0.65 (0.55, 0.77) 0.66 (0.53, 0.83) 
 
56 0.90 (0.53, 1.53) 0.93 (0.48, 1.78) 0.85 (0.45, 1.62) 0.87 (0.39, 1.93) 
Overweight, 25.0-29.9 
   
 
<45 0.88 (0.70, 1.10) 0.81 (0.62, 1.06) 0.78 (0.56, 1.09) 0.78 (0.59, 1.04) 
 
45-49 0.96 (0.87, 1.05) 0.98 (0.85, 1.14) 1.00 (0.85, 1.18) 1.00 (0.76, 1.32) 
 
50-51 Reference Reference Reference Reference 
 
52-53 1.20 (1.06, 1.35) 1.24 (1.06, 1.45) 1.22 (1.06, 1.40) 1.09 (1.02, 1.17) 
 
54-55 1.24 (1.13, 1.35) 1.28 (1.17, 1.40) 1.30 (1.17, 1.44) 1.26 (1.13, 1.41) 
 
56 1.50 (1.31, 1.72) 1.55 (1.35, 1.79) 1.51 (1.38, 1.66) 1.54 (1.41, 1.67) 
Obese, 30 
    
 
<45 1.17 (0.80, 1.72) 1.24 (0.84, 1.83) 1.04 (0.64, 1.67) 1.31 (0.81, 2.13) 
 
45-49 0.97 (0.81, 1.15) 1.07 (0.82, 1.40) 1.13 (0.81, 1.57) 1.08 (0.67, 1.74) 
 
50-51 Reference Reference Reference Reference 
 
52-53 1.22 (1.02, 1.45) 1.28 (0.97, 1.68) 1.28 (1.03, 1.59) 1.23 (1.11, 1.37) 
 
54-55 1.24 (1.07, 1.44) 1.31 (1.07, 1.60) 1.34 (1.08, 1.67) 1.39 (1.18, 1.63) 
 
56 1.52 (1.16, 1.98) 1.61 (1.21, 2.14) 1.64 (1.21, 2.22) 1.80 (1.41, 2.31) 
a
 Data were presented in RRR (95% CI), and all results were adjusted for smoking status, education level, race/ethnicity and number of children. 
b
 The normal weight (18.4-24.9 kg/m2) group was taken as the reference for the polytomous explanatory variable of BMI. 
Abbreviations: BMI, body mass index. 
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Fig. 1 The associations between body mass index and age at natural menopause after 
adjusting for covariates of race/ethnicity, education, smoking status, and number of children 
Fig. 2 Forest plot of study-specific effect of underweight on early menopause (<45 years), overweight 
DQG REHVH RQ ODWH PHQRSDXVH  \HDUV $OO HVWLPDWHV ZHUH IXOO\ adjusted for smoking status, 
education, race/ethnicity, and number of children 
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Fig. 1 The associations between body mass index and age at natural menopause after adjusting 
for covariates of race/ethnicity, education, smoking status, and number of children 
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Fig. 2 Forest plot of study-specific effect of underweight on early menopause (<45 years), overweight 
DQG REHVH RQ ODWH PHQRSDXVH  \HDUV $OO HVWLPDWHV ZHUH IXOO\ adjusted for smoking status, 
education, race/ethnicity, and number of children 
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Table S1. Distribution of body mass index and age at natural menopause in each study (n=24,196) 
Study 
Distribution of BMI  Distribution of age at menopause 
Underweight 
<18.5 
Normal 
18.5-24.9 
Overweight 
25.0-29.9 
Obese  
  <45  45-49 50-51 52-53 54-55 56 
ALSWH 99 (1.8) 2966 (53.9) 1578 (28.7) 862 (15.7)  - 563 (10.2) 1608 (29.2) 1368 (24.9) 1204 (21.9) 762 (13.8) 
MCCS 18 (0.8) 991 (46.4) 735 (34.4) 391 (18.3)  44 (2.1) 412 (19.3) 493 (23.1) 506 (23.7) 402 (18.8) 278 (13.0) 
DNC 5 (3.4) 107 (73.8) 25 (17.2) 8 (5.5)  - 35 (24.1) 34 (23.4) 33 (22.8) 20 (13.8) 23 (15.9) 
WLH 143 (1.5) 6500 (69.5) 2161 (23.1) 549 (5.9)  257 (2.7) 2167 (23.2) 2495 (26.7) 2224 (23.8) 1678 (17.9) 532 (5.7) 
NSHD 17 (2.5) 397 (58.5) 176 (25.9) 89 (13.1)  39 (5.7) 185 (27.2) 190 (28.0) 173 (25.5) 81 (11.9) 11 (1.6) 
NCDS 37 (1.7) 1091 (51.1) 626 (29.3) 381 (17.8)  197 (9.2) 894 (41.9) 192 (9.0) 640 (30.0) 212 (9.9) - 
ELSA 5 (0.8) 242 (40.3) 218 (36.3) 135 (22.5)  2 (0.3) 49 (8.2) 109 (18.2) 155 (25.8) 149 (24.8) 136 (22.7) 
UKWCS 12 (1.6) 531 (69.4) 169 (22.1) 53 (6.9)  28 (3.7) 178 (23.3) 187 (24.4) 195 (25.5) 116 (15.2) 61 (8.0) 
WHITEHALL 29 (2.9) 636 (63.8) 249 (25.0) 83 (8.3)  24 (2.4) 167 (16.8) 278 (27.9) 252 (25.3) 180 (18.1) 96 (9.6) 
SWAN 31 (1.7) 762 (42.8) 456 (25.6) 530 (29.8)  11 (0.6) 457 (25.7) 509 (28.6) 504 (28.3) 245 (13.8) 53 (3.0) 
SMWHS 2 (1.9) 69 (67.0) 17 (16.5) 15 (14.6)  - 24 (23.3) 16 (15.5) 34 (33.0) 21 (20.4) 8 (7.8) 
Total 398 (1.6) 14292 (59.1) 6410 (26.5) 3096 (12.8)  602 (2.5) 5131 (21.2) 6111 (25.3) 6084 (25.1) 4308 (17.8) 1960 (8.1) 
Abbreviations: BMI, body mass index. 
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Table S2. Average age at baseline body mass index collected and age at natural menopause  in each study 
Study N 
Age at baseline BMI collected 
(years) 
 Age at menopause (years) 
Mean (SD) Median (Q1, Q3)  Mean (SD) Median (Q1, Q3) 
ALSWH 5505 47.5 (1.4) 47.4 (46.2, 48.7)  52.5 (2.8) 52.0 (50.0, 55.0) 
MCCS 2135 48.2 (4.1) 48.1 (45.1, 51.1)  51.9 (3.4) 52.0 (50.0, 54.0) 
DNC 145 49.3 (3.4) 49.0 (47.0, 51.0)  52.1 (3.6) 52.0 (50.0, 54.0) 
WLH 9353 44.7 (3.5) 45.0 (42.0, 48.0)  51.1 (3.2) 51.0 (49.0, 53.0) 
NSHD 679 42.7 (1.6) 43.0 (43.0, 43.0)  50.8 (3.3) 51.0 (49.0, 53.0) 
NCDS 2135 45.2 (5.2) 42.0 (42.0, 50.0)  49.4 (3.9) 49.0 (47.0, 53.0) 
ELSA 600 49.4 (3.6) 50.0 (47.0, 52.0)  53.4 (3.1) 53.0 (51.0, 55.0) 
UKWCS 765 49.3 (3.6) 49.4 (47.4, 51.5)  51.1 (3.3) 51.0 (49.0, 53.0) 
WHITEHALL 997 43.3 (4.8) 43.0 (39.0, 47.0)  51.6 (3.1) 52.0 (50.0, 54.0) 
SWAN 1779 46.4 (2.6) 46.0 (44.0, 48.0)  51.1 (2.6) 51.0 (49.0, 53.0) 
SMWHS 103 41.8 (4.2) 41.8 (38.3, 44.9)  52.2 (2.8) 52.5 (50.0, 54.0) 
Total 24196 46.0 (3.8) 46.4 (43.0, 48.8)  51.4 (3.3) 52.0 (50.0, 54.0) 
Abbreviations: BMI, body mass index; SD, standard deviation; Q1, 25th percentile; Q3, 75th percentile. 
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Supplementary Fig.1 Participant flow chart.  
11 prospective studies with women experienced 
menopause after baseline survey were included  
(n=24 196) 
13 prospective studies with no missing data on age at menopause 
were included (n=64 050) 
Excluded women who experienced menopause 
before baseline survey (n=37 691). SABRE study 
was excluded for all women experienced 
menopause before baseline. 
Excluded women with missing covariates of 
smoking, race/ethnicity, education level and parity 
(n= 1650). How study was excluded for missing 
parity variable. 
Excluded women with missing baseline body mass 
index (n=513) 
12 prospective studies included (n=26 359) 
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(A) (B) 
Supplementary Fig.2 The relationship between continuous body mass index and age at menopause: (A) Scatter plot, (B) Fitted 
curve by using fractional-polynomial model. 
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